Compare Eterindo Wahanatama Tbk (ETWA) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eterindo Wahanatama Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Eterindo Wahanatama Tbk trades at Rp70 (market cap 326.81B), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Eterindo Wahanatama Tbk is far larger — about 3.1× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| ETWA | SCPI | |
|---|---|---|
Market Cap | 326.81B | 104.4B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eterindo Wahanatama Tbk
PT Eterindo Wahanatama Tbk or Eterindo is the parent company to midstream specialty chemical companies, interrelated by ownership and through both vertical and horizontal integration. Eterindo has established itself as one of the largest producers of specialty in South East Asia. The products are used as raw material in the production of paints, coatings, adhesives and similar consumer product realm. The breadth of its range gives Eterindo a distinct edge over its competitors.Presently, Eterindo is among the largest producers of plasticizers, an important raw material for producing cables, footwear, tyres and other basic consumer goods, near to one daily usage in life. Modern production facilities, state of the art technology and a highly trained and dedicated labour force means Eterindo companies will continue to offer high quality at competitive prices, to customers at home and overseas. In recognition of its technical achievement, Eterindo has been awarded ISO 9002 certification. Strategic partnership have been formed with multinationals, including Mitsui & Co. Ltd. Of Japan, Kyowa Hakko Kogyo Co. Ltd., Mitsui Bussan Solvent & Coating Co., Ltd., Daewoo Group of Korea and state owned company PT Petrokimia Gresik.
Read more on ETWA →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
